Abstract

Colloidal lipid-based particles offer interesting possibilities in drug delivery, in particular for the administration of poorly water soluble drugs, e.g. into the bloodstream. Such particles can be prepared by high-pressure homogenisation of the respective lipids in an aqueous phase with adequate stabilizers. Since thematerial properties of thematrix lipids in the colloidal state may differ significantly from those of the raw materials adequate characterization of the prepared particles is a very important part of the development work on such systems to ensure the formation of the desired particle properties. X-ray diffraction (XRD) in combinationwith complementarymethods such as, e.g., differential scanning calorimetry (DSC) and electron microscopy, has proven to be a very effective tool for this purpose. Examples will be shown from three different types of lipid drug carrier systems: solid lipid nanoparticles, supercooled smectic nanoparticles and nanoparticles of cubic phase. When solid lipid nanoparticles are prepared via triglyceride melts, a pronounced supercooling effect is often observed which may impair the formation of the desired solid state. Certain emulsifiers can increase the crystallization temperature and thus improve the solidification behaviour of the nanoparticles but their use is often accompanied by additional thermal events prior to triglyceride crystallization. According to XRD these additional thermal events correspond to the crystallization of a surfactant layer at the particle surface which may also include some of the triglyceride in dependence on the composition. The emulsifiers may also modify the polymorphic transitions of the triglycerides after crystallization. Generally, polymorphic transitions are faster in the nanoparticles than in the bulk and sometimes a more stable modification than observed for the bulk material is reached. Also within the colloidal size range different transition rates can be observed with smaller particles transforming faster than larger ones. For small nanoparticles from saturated monoacid triglycerides, a structured melting event is observed in DSC that is not caused by polymorphism but has to be attributed to a particle size effect according to XRD. An influence of the type of emulsifier is also observed for the crystallization behaviour of nanoparticles based on supercooled smectic phase cholesterol esters. The typical bimodal crystallization process observed in phospholipid-containing cholesteryl myristate dispersions is not due to polymorphism as confirmed by XRD but probably reflects the crystallization properties of particles with different shapes. The temperature dependence of different preparation processes for cubic phase nanoparticles based on aqueous monoolein/poloxamer systems seems to be related to the phase behaviour as indicated by results from small angle XRD. m37.o05

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call